ANIX- Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Activity
Buys and sells only
Transactions
10 filings · page 15
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2015 | Berman Robert Andrew | President And CEO | Buy | 200 | $4.00 | $800.00 | +0.5% | |
| Jul 7, 2015 | Berman Robert Andrew | President And CEO | Buy | 200 | $3.80 | $760.00 | +0.5% | |
| Jul 7, 2015 | Johnson Bruce F | Director | Buy | 6,500 | $3.62 | $23,530.00 | +1.8% | |
| Jul 6, 2015 | Kumar Amit62 | Director | Buy | 3,500 | $3.94 | $13,790.00 | +4.0% | |
| Jul 1, 2015 | Berman Robert Andrew | President And CEO | Buy | 1,100 | $3.84 | $4,225.00 | +1.4% | |
| Jun 30, 2015 | Kumar Amit62 | Director | Buy | 1,700 | $3.98 | $6,766.00 | +2.0% | |
| Jun 29, 2015 | Kumar Amit62 | Director | Buy | 2,000 | $3.95 | $7,900.00 | +2.4% | |
| Jun 29, 2015 | Berman Robert Andrew | President And CEO | Buy | 1,712 | $4.24 | $7,258.00 | +2.3% | |
| Jun 26, 2015 | Johnson Bruce F | Director | Buy | 6,000 | $3.95 | $23,700.00 | +1.7% | |
| Jun 26, 2015 | Kumar Amit62 | Director | Buy | 100 | $8.95 | $895.00 | +0.1% |